Abstract
Novel thiadiazole derivatives bearing hydrazone moieties were synthesized through the reaction of 2-[(5-methyl-1,3,4-thiadiazol-2-yl)thio)]acetohydrazide with aldehydes/ketones. The chemical structures of the compounds were elucidated by 1H-NMR, 13C-NMR, MS-FAB spectral data, and elemental analyses. Behavioral effects of the test compounds in mice were examined by hole-board, activity cage, tail suspension and modified forced swimming tests (MFST). Antinociceptive activities were evaluated using the hot-plate and tail-clip methods. Results of the experiments indicated that the test compounds did not significantly change the exploratory behaviors or locomotor activities of animals in the hole-board and activity cage tests, respectively. Administration of the reference drug fluoxetine (10 mg/kg) and compounds 3a, 3b, 3c, 3j, 3k, and 3l significantly shortened the immobility times of animals in the tail suspension and MFST tests, indicating the antidepressant-like effects of these derivatives. Morphine (10 mg/kg) and compounds 3a, 3b, 3c, 3d, 3e, 3j, 3k, and 3l increased the reaction times of mice in both the hot-plate and tail-clip tests, indicating the antinociceptive effects of these compounds. To the best of our knowledge, this is the first study of central nervous system activities of chemical compounds carrying thiadiazole and hydrazone moieties together on their structures.
Similar content being viewed by others
References
Brufani, M., Loche, A., Perlini, V., and Pocar, D., Preparation of 2-amino-5-[(ar)alkylthio]thiadiazoles as antidepressant. EUR. Patent 579,129 (1994).
Can, O. D., Ozkay, U. D., Kaplancikli, Z. A., and Oztürk, Y., Effects of some 1,3,5-trisubstitued-2-pyrazoline derivatives on depression and anxiety parameters of mice. Arch. Pharm. Res., 32, 1293–1299 (2009).
Can, O. D., Ozkay, U. D., Oztürk, N., and Oztürk, Y., Effects of hawthorn seed and pulp extracts on the central nervous system. Pharm. Biol., 48, 924–931 (2010).
Can, O. D., Ismail, I. B., Öztürk, Y., Öztürk, N., Potooğlu-Erkara, S. H., Sagratini, G., Ricciutelli, M., Vittori, S., and Maggi, F., New antidepressant drug candidate: Hypericum montbretti extract. Nat. Prod. Res., 25, 1469–1472 (2011).
Chapleo, C. B., Myers, M., Myers, P. L., Saville, J. F., Smith, A. C., Stillings, M. R., Tulloch, I. F., Walter, D. S., and Welbourn, A. P., Substituted 1,3,4-thiadiazoles with anticonvulsant activity. 1. Hydrazines. J. Med. Chem., 29, 2273–2280 (1986).
Chufán, E. E., Pedregosa, J. C., Baldini, O. N., and Bruno-Blanch, L., Anticonvulsant activity of analogues of acetazolamide. Farmaco, 54, 834–841 (1999).
Ciapetti, P. and Giethlen, B., Molecular variations based on isosteric replacements, In Wermuth, C. M. (Ed.). The Practice of Medicinal Chemistry. Academic Press, Burlington, pp. 290–342, (2008).
Clerici, F. and Pocar, D., Synthesis of 2-Amino-5-sulfanyl-1,3,4-thiadiazole derivatives and evaluation of their antidepressant and anxiolytic activity. J. Med. Chem., 44, 931–936 (2001).
Cryan, J. F., Markou, A., and Lucki, I., Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol. Sci., 23, 238–245 (2002).
D’Amour, F. E. and Smith, D. L., A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther., 72, 74–79 (1941).
Despaigne, A. A. R., Vieira, L. F., Mendes, I. C., da Costa, F. B., Spezialib, N. L., and Beraldo, H., Organotin(IV) complexes with 2-acetylpyridine benzoyl hydrazones: antimicrobial activity. J. Braz. Chem. Soc., 21, 1247–1257 (2010).
Dharmshaktu, P., Tayal, V., and Kalra, B. S., Efficacy of antidepressants as analgesics: A review. J. Clin. Pharmacol., 52, 6–17 (2012).
Ergenç, N., Günay, N. S., and Demirdamar, R., Synthesis and antidepressant evaluation of new 3-phenyl-5-sulfonamidoindole derivatives. Eur. J. Med. Chem., 33, 143–148 (1998).
Gabra, B. H. and Sirois, P., Beneficial effect of chronic treatment with the selective bradykinin B1 receptor antagonists, R-715 and R-954, in attenuating streptozotocin-diabetic thermal hyperalgesia in mice. Peptides, 24, 1131–1139 (2003).
Kaplancikli, Z. A., Turan-Zitouni, G., Ozdemir, A., Can, O., and Chevallet, P., Synthesis and antinociceptive activities of some pyrazoline derivatives. Eur. J. Med. Chem., 44, 2606–2610 (2009).
Kaplancikli, Z. A., Ozdemir, A., Turan-Zitouni, G., Altintop, M. D., and Can, O. D., New pyrazoline derivatives and their antidepressant activity. Eur. J. Med. Chem., 45, 43834387 (2010).
Kidwai, M. and Kumar, P., Microwave-induced syntheses of 6-(substituted aryl)-3-[(5-methyl-1,3,4-thiadiazol-2-ylsulfanyl) methyl]-1,2,4-triazolo[3,4-b][1,3,4]thiadiazoles. J. Chem. Res. Synop., 5, 254–255 (1996).
Korzeniewska-Rybicka, I. and Plaznik, A., Supraspinally mediated analgesic effect of antidepressant drugs. Pol. J. Pharmacol., 52, 93–99 (2000).
Lima, L. M. and Barreiro, E. J., Bioisosterism: A useful strategy for molecular modification and drug design. Curr. Med. Chem., 12, 23–49 (2005).
Özdemir, A., Turan-Zitouni, G., Kaplancikli, Z. A., and Tunalı, Y., Synthesis and biological activities of new hydrazide derivatives. J. Enzym. Inhib. Med. Chem., 24, 825–831 (2009).
Pandey, A., Dewangan, D., Verma, S., Mishra, A., and Dubey, R. D., Synthesis of Schiff bases of 2-amino-5-aryl-1,3,4-thiadiazole and its analgesic, anti-inflammatory, antibacterial and anti-tubercular activity. Int. J. ChemTech Res., 3, 178–184 (2011).
Patani, G. A. and LaVoie, E. J., Bioisosterism: A rational approach in drug design. Chem. Rev., 96, 3147–3176 (1996).
Pattanayak, P., Sharma R., and Sahoo, P. K., Synthesis and evaluation of 2-amino-5-sulfanyl-1,3,4-thiadiazoles as antidepressant, anxiolytic, and anticonvulsant agents. Med. Chem. Res., 18, 351–361 (2009).
Pavin, N. F., Donato, F., Cibin, F. W., Jesse, C. R., Schneider, P. H., de Salles, H. D., Soares, L. D., Alves, D., and Savegnago, L., Antinociceptive and anti-hypernociceptive effects of Se-phenyl thiazolidine-4-carboselenoate in mice. Eur. J. Pharmacol., 668, 169–176 (2011).
Ragavendran, J. V., Sriram, D., Patel, S. K., Reddy, I. V., Bharathwajan, N., Stables, J., and Yogeeswari, P., Design and synthesis of anticonvulsants from a combined phthalimide-GABA-anilide and hydrazone pharmacophore. Eur. J. Med. Chem., 42, 146–151 (2007).
Rajak, H., Deshmukh, R., Aggarwal, N., Kashaw, S., Kharya, M. D., and Mishra, P., Synthesis of novel 2,5-disubstituted 1,3,4-thiadiazoles for their potential anticonvulsant activity: pharmacophoric model studies. Arch. Pharm. (Weinheim), 342, 453–461 (2009).
Rollas, S. and Küçükgüzel, Ş. G., Biological activities of hydrazone derivatives. Molecules, 12, 1910–1939 (2007).
Salgin-Gökşen, U., Gökhan-Kelekçi, N., Göktaş, O., Köysal, Y., Kiliç, E., Işik, S., Aktay, G., and Ozalp, M., 1-Acylthiosemicarbazides, 1,2,4-triazole-5(4H)-thiones, 1,3,4-thiadiazoles and hydrazones containing 5-methyl-2-benzoxazolinones: synthesis, analgesic-anti-inflammatory and antimicrobial activities. Bioorg. Med. Chem., 15, 5738–5751 (2007).
Sharma, R., Misra, G. P., Sainy, J., and Chaturvedi, S. C., Synthesis and biological evaluation of 2-amino-5-sulfanyl-1,3,4-thiadiazole derivatives as antidepressant, anxiolytics and anticonvulsant agents. Med. Chem. Res., 20, 245–253 (2011).
Siddiqui, N., Ahuja, P., Ahsan, W., Pandeya, S. N., and Shamsher Alam, M., Thiadiazoles: Progress report on biological activities. J. Chem. Pharm. Res., 1, 19–30 (2009).
Silva, G. A., Costa, L. M., Brito, F. C., Miranda, A. L., Barreiro, E. J., and Fraga, C. A., New class of potent antinociceptive and antiplatelet 10H-phenothiazine-1-acylhydrazone derivatives. Bioorg. Med. Chem., 12, 3149–3158 (2004).
Silverman, R. B., The organic chemistry of drug design and drug action. Elsevier Academic Press, Burlington, pp. 53–62, (2004).
Steru, L., Chermat, R., Thierry, B., and Simon, P., The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacol. (Berl), 85, 367–370 (1985).
Stillings, M. R., Welbourn, A. P., and Walter, D. S., Substituted 1,3,4-thiadiazoles with anticonvulsant activity. 2. aminoalkyl derivatives. J. Med. Chem., 29, 2280–2284 (1986).
Takeda, H., Tsuji, M., and Matsumiya, T., Changes in headdipping behavior in the hole-board test reflect the anxiogenic and/or anxiolytic state in mice. Eur. J. Pharmacol., 350, 21–29 (1998).
Tanaka, M. and Telegdy, G., Involvement of adrenergic and serotonergic receptors in antidepressant-like effect of Urocortin 3 in a modified forced swimming test in mice. Brain Res. Bull., 77, 301–305 (2008).
Varvaresou, A., Siatra-Papastaikoudi, T., Tsotinis, A., Tsantili-Kakoulidou, A., and Vamvakides, A., Synthesis, lipophilicity and biological evaluation of indole-containing derivatives of 1,3,4-thiadiazole and 1,2,4-triazole. Farmaco, 53, 320–326 (1998).
Waterbeemd, H. and Mannhold, R., Lipophilicity descriptors for structure-property correlation studies: Overview of experimental and theoretical methods and a benchmark of log P calculations, In: Mannhold, R., Kubinyi, H., and Timmerman, H. (Series Eds.), Pliska, V., Testa, B., Waterbeemd, H. (Vol. Eds.). Lipophilicity in Drug Action and Toxicology. VCH Publishers, New York, pp. 401–418, (1996).
Watson, C. P., Gilron, I., Sawynok, J., and Lynch, M. E., Nontricyclic antidepressant analgesics and pain: are serotonin norepinephrine reuptake inhibitors (SNRIs) any better? Pain, 152, 2206–2210 (2011).
Wong, C. H., Day, P., Yarmush, J., Wu, W., and Zbuzek, U. K., Nifedipine induced analgesic after epidural injections in rats. Anesth. Anal., 79, 303–306 (1994).
Woolfre, H. G. and MacDonald, A. D., The evaluation of the analgesic action of pethidine hydrochloride (Demerol). J. Pharmacol. Exp. Ther., 80, 300–307 (1944).
Yusuf, M., Khan, R. A., and Ahmed, B., Syntheses and antidepressant activity of 5-amino-1,3,4-thiadiazole-2-thiol imines and thiobenzyl derivatives. Bioorg. Med. Chem., 16, 8029–8034 (2008).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Can, Ö.D., Altıntop, M.D., Özkay, Ü.D. et al. Synthesis of thiadiazole derivatives bearing hydrazone moieties and evaluation of their pharmacological effects on anxiety, depression, and nociception parameters in mice. Arch. Pharm. Res. 35, 659–669 (2012). https://doi.org/10.1007/s12272-012-0410-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-012-0410-6